Results 151 to 160 of about 490,601 (215)

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery (CRS): Age-Related Outcomes and a Look into the Future. [PDF]

Cancers (Basel)
Aguirre S, Haley JK, Broski JA, Baker J, Selby LV, Umar S, Al-Kasspooles MF.   +6 more
europepmc   +1 more source

Cytoreductive Surgery (CS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Postoperative Evolution, Adverse Outcomes and Perioperative Risk Factors. [PDF]

Healthcare (Basel)
Valencia-Sola L, Becerra-Bolaños Á, Mateo-Ferragut M, Muiño-Palomar V, Ojeda-Betancor N, Rodríguez-Pérez A.   +5 more
europepmc   +1 more source

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for children and young adults: experience from two high volume centers. [PDF]

Pleura Peritoneum
Eckert M, Gerken M, Werner JM, Blaj S, Füsi F, Bogovic N, Schlitt HJ, Hornung M, Piso P, Acs M.   +9 more
europepmc   +1 more source

Outcomes following diagnostic laparoscopy in patients with peritoneal carcinomatosis deemed ineligible for cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) due to disease burden. [PDF]

Surg Oncol Insight
Smith PM, Seldomridge A, Chiang YJ, White MG, Song Y, Scally C, Mansfield PF, Fournier KF, Helmink BA.   +8 more
europepmc   +1 more source

Single center experience with Hypotension Prediction Index (HPI) during cytoreductive surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). [PDF]

J Anesth Analg Crit Care
L'Acqua C, Frassanito L, Kusamura S, Valenza F.   +3 more
europepmc   +1 more source

CD8 + T-cells restrict the development of peritoneal metastasis and support the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC). [PDF]

Sci Rep
Roth L, Huynh-Russo L, Heeb L, Ulugöl S, Freire Dos Santos R, Breuer E, Ungethüm U, Haberecker M, Pauli C, Koelzer V, Lehmann K, Gupta A.   +11 more
europepmc   +1 more source

Correction to "Implementation of a Multidisciplinary Enhanced Recovery After Surgery (ERAS) Program for Cytoreductive Surgery (CRS) With Hyperthermic Intraperitoneal Chemotherapy (HIPEC)". [PDF]

J Surg Oncol
europepmc   +1 more source

INDEPSO-ISPSM consensus on peritoneal malignancies - Enhanced recovery after surgery in cytoreductive surgery (CRS) with/without hyperthermic intraperitoneal chemotherapy (HIPEC). [PDF]

Gynecol Oncol Rep
Prakash Bhandoria G, Guru A, Pawar A, Bhatt A, Kumar N, Kumar R, Patel S, Lal Solanki S, Sukumar V, Rajagopal AK, Somashekhar SP.   +10 more
europepmc   +1 more source

Implementation of a Multidisciplinary Enhanced Recovery After Surgery (ERAS) Program for Cytoreductive Surgery (CRS) With Hyperthermic Intraperitoneal Chemotherapy (HIPEC). [PDF]

J Surg Oncol
Stockley C, Bouchard-Fortier A, Mateshaytis J, Taqi K, Mack L, Nelson G, Chong M, Deban M.   +7 more
europepmc   +1 more source